Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In FDA Actions
FDA Actions for January/February 2018
Lutathera Approved for Rare GI Malignancies, FDA news release; 2018 Jan 26
FDA Actions for November/December 2017
Clenpiq Approved as Oral Solution for Colonoscopy Prep, Ferring news release; 2017 Nov 29
FDA Approves Mepsevii for MPS VII, FDA news release; 2017 Nov 25
FDA Actions for September/October 2017
Senhance System Cleared by FDA for Robotic Surgery, FDA news release; 2017 Oct 13
Opdivo Approved for Hepatocellular Carcinoma, Bristol-Myers Squibb news release; 2017 Sep 22
FDA Actions for July/August 2017
Mavyret Approved for Chronic Hepatitis C, FDA news release; 2017 Aug 3
Pertzye Now Available in Delayed-Release Capsules, Digestive Care news release; 2017 Jul 12
Vectibix Approved for Wild-Type RAS Metastatic CRC, Amgen news release; 2017 Jun 29
FDA Actions for May/June 2017
FDA Approves Device to Treat Esophageal Atresia, FDA news release; 2017 May 12